Bone structure and function

Diagnostic Imaging of Musculoskeletal Diseases: A Systematic Approach

Volumn , Issue , 2010, Pages 1-13

  Safadi, Fayez F ^a,b   Khurana, Jasvir S ^a,c  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (Qatar)

^c TEMPLE UNIVERSITY HOSPITAL   (United States)

Author keywords

Alkaline phosphatase; Androgen; Bone morphogenetic proteins (BMPs); Calcium hydroxyapatite; Collagen; Cortical; Coupling; Diaphysis; Endosteum; Epiphysis; Estrogen; Formation; Glycosaminoglycans; Insulin like growth factors (IGFs); Lamellar; Metaphysis; Mineralization; Non collagenous proteins; Osteoblasts; Osteocalcin; Osteoclasts; Osteopontin; Parathyroid hormone; Periosteum; Platelet derived growth factors (PDGFs); Proteoglycans; Receptor activator of nuclear factor kappa B (RANK); Remodeling; Resorption; Trabecular; Transforming growth factor beta (TGF ); Vitamin A; Vitamin D; Wolff's law; Woven

Indexed keywords

EID: 84887962113     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-59745-355-4_1     Document Type: Chapter

References (43)

1. Bliziotes M, Gunness M, Eshleman A, Wiren K. The role of dopamine and serotonin in regulating bone mass and strength: studies on dopamine and serotonin transporter null mice. J Musculoskelet Neuronal Interact 2002;2(3):291-295.
2. Idris AI, Van't Hof RJ, Greig IR, et al. Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors. Nat Med 2005;11(7):774-779.
3. Tam J, Ofek O, Fride E, et al. Involvement of neuronal cannabinoid receptor CB1 in regulation of bone mass and bone remodeling. Mol Pharmacol 2006;70(3):786-792.
4. Hohling HJ, Barckhaus RH, Drefting ER, Quint P, Athoff J. Quantitative electron microscopy of the early stages of cartilage mineralization. Metab Bone Dis Relat Res 1978;1:109-114.
5. Landis WJ, Song MJ, Leith A, McEwen L, McEwen BF. Mineral and organic matrix interaction in normally calcifying tendon visualized in three dimensions by high-voltage electron microscopic tomography and graphic image reconstruction. J Struct Biol 1993;110(1):39-54.
6. Khan SN, Bostrom MP, Lane JM. Bone growth factors. Orthop Clin North Am 2000;31(3):375-388.
7. Rodan GA. Control of bone formation and resorption: biological and clinical perspective. J Cell Biochem Suppl 1998;30-31:55-61.
8. Komori T, Yagi H, Nomura S, et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 1997;89(5):755-764.
9. Otto F, Thornell AP, Crompton T, et al. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 1997;89(5):765-771.
10. Ducy P, Amling M, Takeda S, et al. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 2000;100(2):197-207.
11. Takahashi N, Yamana H, Yoshiki S, et al. Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures. Endocrinology 1988;122(4):1373-1382.
12. Watanabe H, Yanagisawa T, Sasaki J. Cytoskeletal architecture of rat calvarial osteoclasts: microfilaments, and intermediate filaments, and nuclear matrix as demonstrated by detergent perfusion. Anat Rec 1995;243(2):165-174.
13. Horne WC. Toward a more complete molecular description of the osteoclast. Bone 1995;17(2):107-109.
14. Sakai D, Tong HS, Minkin C. Osteoclast molecular phenotyping by random cDNA sequencing. Bone 1995;17(2):111-119.
15. Manolagas SC, Jilka RL. Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N Engl J Med 1995;332(5):305-311.
16. Ohsaki Y, Takahashi S, Scarcez T, et al. Evidence for an autocrine/paracrine role for interleukin-6 in bone resorption by giant cells from giant cell tumors of bone. Endocrinology 1992;131(5):2229-2234.
17. Roodman GD, Kurihara N, Ohsaki Y, et al. Interleukin 6. A potential autocrine/paracrine factor in Paget's disease of bone. J Clin Invest 1992;89(1):46-52.
18. Bucay N, Sarosi I, Dunstan CR, et al. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 1998;12(9):1260-1268.
19. Dougall WC, Glaccum M, Charrier K, et al. RANK is essential for osteoclast and lymph node development. Genes Dev 1999;13(18):2412-2424.
20. Hughes AE, Ralston SH, Marken J, et al. Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis. Nat Genet 2000;24(1):45-48.
21. Kong YY, Feige U, Sarosi I, et al. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 1999;402(6759):304-309.
22. Kong YY, Yoshida H, Sarosi I, et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 1999;397(6717):315-323.
23. Lacey DL, Timms E, Tan HL, et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998;93(2):165-176.
24. Wong BR, Rho J, Arron J, et al. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun. N-terminal kinase in T cells. J Biol Chem 1997;272(40):25190-25194.
25. Yasuda H, Shima N, Nakagawa N, et al. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology 1998;139(3):1329-1337.
26. Yasuda H, Shima N, Nakagawa N, et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 1998;95(7):3597-3602.
27. Sela J, Amir D, Schwartz Z, Weinberg H. Ultrastructural tissue morphometry of the distribution of extracellular matrix vesicles in remodeling rat tibial bone six days after injury. Acta Anat (Basel) 1987;128(4):295-300.
28. Ressoret J, De Crombrugghe B. Type I collagen. In: JP Bilezikian LGR, GA Rodan (Eds.), Principels of Bone Biology, 2nd ed. San Diego: Academic Press, 2002;189-210.
29. Ishida T, Machinami R. Reactive bone and cartilage forming processes of the hands and feet. Pathol Int 1995;45(12):975-976.
30. Manolagas SC, Bellido T, Jilka RL. New insights into the cellular, biochemical, and molecular basis of postmenopausal and senile osteoporosis: roles of IL-6 and gp130. Int J Immunopharmacol 1995;17(2):109-116.
31. Huebner AK, Schinke T, Priemel M, et al. Calcitonin deficiency in mice progressively results in high bone turnover. J Bone Miner Res 2006;21(12):1924-1934.
32. Mundy GR, Boyce B, Hughes D, et al. The effects of cytokines and growth factors on osteoblastic cells. Bone 1995;17(2 Suppl):71S-75S.
33. Morrison NA, Qi JC, Tokita A, et al. Prediction of bone density from vitamin D receptor alleles. Nature 1994;367(6460):284-287.
34. Urist MR, McLF. Osteogenetic potency and new-bone formation by induction in transplants to the anterior chamber of the eye. J Bone Joint Surg Am 1952;34-A(2):443-476.
35. Kessler E, Takahara K, Biniaminov L, Brusel M, Greenspan DS. Bone morphogenetic protein-1: the type I procollagen C-proteinase. Science (New York) 1996;271(5247):360-362.
36. Reddi AH. BMP-1: resurrection as procollagen C-proteinase. Science (New York) 1996;271(5248):463.
37. Urist MR, De Lange RJ, Finerman GA. Bone cell differentiation and growth factors. Science (New York) 1983;220(4598):680-686.
38. Urist MR, Sato K, Brownell AG, et al. Human bone morphogenetic protein (hBMP). Proc Soc Exp BiolMed (New York) 1983;173(2):194-199.
39. Urist MR, Wallace TH, Adams T. The function of fibrocartilaginous fracture callus. Observations on transplants labelled with tritiated thymidine. J Bone Joint Surg 1965;47:304-318.
40. Wozney JM, Rosen V, Celeste AJ, et al. Novel regulators of bone formation: molecular clones and activities. Science (New York) 1988;242(4885):1528-1534.
41. Cook SD, Salkeld SL, Rueger DC. Evaluation of recombinant human osteogenic protein-1 (rhOP-1) placed with dental implants in fresh extraction sites. J Oral Implantol 1995;21(4):281-289.
42. Cook SD, Wolfe MW, Salkeld SL, Rueger DC. Effect of recombinant human osteogenic protein-1 on healing of segmental defects in non-human primates. J Bone Joint Surg Am 1995;77(5):734-750.
43. Shimizu T, Okayama A, Inoue T, Takeda K. Analysis of gene expression during staurosporine-induced neuronal differentiation of human prostate cancer cells. Oncol Rep 2005;14(2):441-448.